Financials
- Market Capitalization 5.92 M
- Employee 2
- Founded 2003
- CEO N/A
- Website www.pulmatrix.com
- Headquarter Delaware, United States
- FIGI BBG003TH2QL1
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-1.58
Rapporto prezzo/fatturato
—
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 4923 | PCSA Processa Pharmaceuticals, Inc. - Common Stock | 2.30 USD | +11.65% | +21.69% | +5.02% | +3.38% | 6.33 M USD | ||
| 4931 | CURX Curanex Pharmaceuticals Inc - Common Stock | 0.21 USD | 0.00% | -16.00% | -34.38% | -94.47% | 5.96 M USD | ||
| 4939 | APVO Aptevo Therapeutics Inc. - Common Stock | 4.62 USD | +11.33% | +1.99% | -0.43% | -31.56% | 5.76 M USD | ||
| 4942 | ADIL Adial Pharmaceuticals, Inc - Common Stock | 2.65 USD | -6.36% | -7.67% | -5.36% | +597.37% | 5.68 M USD |